153 related articles for article (PubMed ID: 10577582)
1. Recurrent ocular disease in postnatally acquired toxoplasmosis.
Bosch-Driessen EH; Rothova A
Am J Ophthalmol; 1999 Oct; 128(4):421-5. PubMed ID: 10577582
[TBL] [Abstract][Full Text] [Related]
2. Ocular toxoplasmosis: clinical features and prognosis of 154 patients.
Bosch-Driessen LE; Berendschot TT; Ongkosuwito JV; Rothova A
Ophthalmology; 2002 May; 109(5):869-78. PubMed ID: 11986090
[TBL] [Abstract][Full Text] [Related]
3. Active ocular toxoplasmosis in Turkish patients: a report on 109 cases.
Tugal-Tutkun I; Corum I; Otük B; Urgancioglu M
Int Ophthalmol; 2005 Dec; 26(6):221-8. PubMed ID: 17318320
[TBL] [Abstract][Full Text] [Related]
4. Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis.
Delair E; Monnet D; Grabar S; Dupouy-Camet J; Yera H; Brézin AP
Am J Ophthalmol; 2008 Dec; 146(6):851-5. PubMed ID: 18723143
[TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations of ocular toxoplasmosis.
Delair E; Latkany P; Noble AG; Rabiah P; McLeod R; Brézin A
Ocul Immunol Inflamm; 2011 Apr; 19(2):91-102. PubMed ID: 21428746
[TBL] [Abstract][Full Text] [Related]
6. Time patterns of recurrences and factors predisposing for a higher risk of recurrence of ocular toxoplasmosis.
Reich M; Ruppenstein M; Becker MD; Mackensen F
Retina; 2015 Apr; 35(4):809-19. PubMed ID: 25299969
[TBL] [Abstract][Full Text] [Related]
7. Ocular manifestations in congenital toxoplasmosis.
Kodjikian L; Wallon M; Fleury J; Denis P; Binquet C; Peyron F; Garweg JG
Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):14-21. PubMed ID: 15906073
[TBL] [Abstract][Full Text] [Related]
8. Retinal detachment associated with ocular toxoplasmosis.
Faridi A; Yeh S; Suhler EB; Smith JR; Flaxel CJ
Retina; 2015 Feb; 35(2):358-63. PubMed ID: 25127047
[TBL] [Abstract][Full Text] [Related]
9. Eye manifestations of congenital toxoplasmosis.
Mets MB; Holfels E; Boyer KM; Swisher CN; Roizen N; Stein L; Stein M; Hopkins J; Withers S; Mack D; Luciano R; Patel D; Remington JS; Meier P; McLeod R
Am J Ophthalmol; 1996 Sep; 122(3):309-24. PubMed ID: 8794703
[TBL] [Abstract][Full Text] [Related]
10. Eye manifestations of congenital toxoplasmosis.
Mets MB; Holfels E; Boyer KM; Swisher CN; Roizen N; Stein L; Stein M; Hopkins J; Withers S; Mack D; Luciano R; Patel D; Remington JS; Meier P; McLeod R
Am J Ophthalmol; 1997 Jan; 123(1):1-16. PubMed ID: 9186091
[TBL] [Abstract][Full Text] [Related]
11. [Acquired toxoplasmosis of ocular or neurologic site: 49 cases].
Couvreur J; Thulliez P
Presse Med; 1996 Mar; 25(9):438-42. PubMed ID: 8685192
[TBL] [Abstract][Full Text] [Related]
12. Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection.
Ongkosuwito JV; Bosch-Driessen EH; Kijlstra A; Rothova A
Am J Ophthalmol; 1999 Oct; 128(4):407-12. PubMed ID: 10577580
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of visual field over 6 months after active ocular toxoplasmosis.
Blot J; Aptel F; Chumpitazi BFF; Gain P; Vasseneix C; Savy O; Bouillet L; Pelloux H; Chiquet C
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1481-1488. PubMed ID: 31037491
[TBL] [Abstract][Full Text] [Related]
14. Ocular toxoplasmosis: an update and review of the literature.
Commodaro AG; Belfort RN; Rizzo LV; Muccioli C; Silveira C; Burnier MN; Belfort R
Mem Inst Oswaldo Cruz; 2009 Mar; 104(2):345-50. PubMed ID: 19430662
[TBL] [Abstract][Full Text] [Related]
15. Controversies in ocular toxoplasmosis.
Wakefield D; Cunningham ET; Pavesio C; Garweg JG; Zierhut M
Ocul Immunol Inflamm; 2011 Feb; 19(1):2-9. PubMed ID: 21250922
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
[TBL] [Abstract][Full Text] [Related]
17. Long-term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children.
Faucher B; Garcia-Meric P; Franck J; Minodier P; Francois P; Gonnet S; L'ollivier C; Piarroux R
J Infect; 2012 Jan; 64(1):104-9. PubMed ID: 22051915
[TBL] [Abstract][Full Text] [Related]
18. Orally administered 566C80 for treatment of ocular toxoplasmosis in a patient with the acquired immunodeficiency syndrome.
Lopez JS; de Smet MD; Masur H; Mueller BU; Pizzo PA; Nussenblatt RB
Am J Ophthalmol; 1992 Mar; 113(3):331-3. PubMed ID: 1543229
[No Abstract] [Full Text] [Related]
19. Ocular toxoplasmosis after the fifth decade.
Labalette P; Delhaes L; Margaron F; Fortier B; Rouland JF
Am J Ophthalmol; 2002 Apr; 133(4):506-15. PubMed ID: 11931784
[TBL] [Abstract][Full Text] [Related]
20. Reactivation of ocular toxoplasmosis in fellow unaffected eye.
Seng Lee M; Boyce RL; Clarke JR
Eur J Ophthalmol; 2004; 14(4):338-40. PubMed ID: 15309981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
